EP 0716596 B8 20071003 - NEW PHARMACEUTICAL COMPOSITIONS FOR TOPICAL USE CONTAINING HYALURONIC ACID AND ITS DERIVATIVES
Title (en)
NEW PHARMACEUTICAL COMPOSITIONS FOR TOPICAL USE CONTAINING HYALURONIC ACID AND ITS DERIVATIVES
Title (de)
HYALURONSÄURE UND DEREN DERIVATE ENTHALTENDE ARZNEIMITTEL ZUR TOPISCHEN ANWENDUNG
Title (fr)
NOUVELLES COMPOSITIONS PHARMACEUTIQUES A USAGE TOPIQUE RENFERMANT DE L'ACIDE HYALURONIQUE ET SES DERIVES
Publication
Application
Priority
- EP 9402536 W 19940729
- IT PD930165 A 19930730
Abstract (en)
[origin: WO9503786A2] Provided is a pharmaceutical composition, comprising a pharmaceutically effective amount of an acidic polysaccharide and/or a derivative thereof, a gaseous vehicle, and a pharmaceutically acceptable carrier or excipient. Said acidic polysaccharide or derivative thereof can be hyaluronic acid, a pharmaceutically acceptable salt of hyaluronic acid, a partial or total ester of hyaluronic acid with an alcohol, a partial or total intermolecular ester of hyaluronic acid, a partial or total intramolecular ester of hyaluronic acid, a cross-linked ester of hyaluronic acid, an alginic acid ester, an ester of carboxymethylcellulose, an ester of carboxymethylchitin, an ester of carboxymethyl starch, a gellan ester, a cross-linked gellan ester, a pectic acid ester, and a pectinic acid ester. The composition can contain one or more topical drugs, and can be in the form of an aerosol or liquid spray, a foam, or a dry spray. The composition is useful in the treatment of a variety of pathological situations requiring the acceleration of tissue repair, for example in the treatment of burns, sores, ulcerations, and wounds. Also provided is a therapeutic method, comprising topically administering a pharmaceutical composition comprising a pharmaceutically effective amount of an acidic polysaccharide and/or a derivative thereof in association with a gaseous vehicle and a pharmacologically acceptable excipient, and optionally, one or more topical drugs.
IPC 8 full level
A61K 9/12 (2006.01); A61K 31/715 (2006.01); A61K 31/728 (2006.01); A61L 26/00 (2006.01)
CPC (source: EP US)
A61K 9/12 (2013.01 - EP US); A61K 9/122 (2013.01 - EP US); A61K 31/715 (2013.01 - EP US); A61L 26/0023 (2013.01 - EP US); A61L 26/0076 (2013.01 - EP US)
C-Set (source: EP US)
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
Designated extension state (EPC)
LT SI
DOCDB simple family (publication)
WO 9503786 A2 19950209; WO 9503786 A3 19950316; AT E365033 T1 20070715; AU 7534194 A 19950228; DE 69434992 D1 20070802; DE 69434992 T2 20071206; EP 0716596 A1 19960619; EP 0716596 B1 20070620; EP 0716596 B8 20071003; ES 2288298 T3 20080101; IT 1263394 B 19960805; IT PD930165 A0 19930730; IT PD930165 A1 19950130; PT 716596 E 20070820; US 2002132790 A1 20020919; US 6509322 B2 20030121
DOCDB simple family (application)
EP 9402536 W 19940729; AT 94925418 T 19940729; AU 7534194 A 19940729; DE 69434992 T 19940729; EP 94925418 A 19940729; ES 94925418 T 19940729; IT PD930165 A 19930730; PT 94925418 T 19940729; US 29087399 A 19990414